AC2101 SemGrp4 Team10 Updated
AC2101 SemGrp4 Team10 Updated
AC2101 SemGrp4 Team10 Updated
Employee Benefits
AC2101
Seminar Group 4
Team 10
Pamela Keh, Tan Jia Teng, Tan Xin Rong, Low Zi He, Loh Lee Kheng
1
Part I: Question 1
2
Part I: Question 1
TRUE
3
Part I: Question 2
Liability Equity
5
Part I: Question 2
FALSE
(a) receives goods or services as consideration for its own equity instruments (including
shares or share options), or
(b) receives goods or services but has no obligation to settle the transaction with the
supplier.
6
Part I: Question 3
APPRECIATION
These arrangements are examples of cash-settled share-based
RIGHTS payment transactions. [ SFRS(I) 2 Para 31 ]
The liability shall be measured, initially and at the end of each reporting period until
settled, at the fair value of the share appreciation rights, by applying an option pricing model…
1. FV is NOT estimated at date of grant but is remeasured at the end of each reporting
period.
2. Amount expensed will be adjusted accordingly over the vesting period
9
Part I: Question 4
10
Part I: Question 4
FALSE
Expectations about the future are generally based on experience, modified if the future is
reasonably expected to differ from the past.
11
Part I: Question 4
SFRS (I) 2 Para B13
For example, if an entity with two distinctly different lines of business disposes of the one that was
significantly less risky than the other, historical volatility may not be the best information on which to
base reasonable expectations for the future.
2
In other circumstances, historical information may not be available.
For example, a newly listed entity will have little, if any, historical data on the volatility of its share
price.
12
Part I: Question 4
FALSE
In summary, an entity should not simply base estimates of volatility, exercise behaviour
and dividends on historical information without considering the extent to which the past
experience is expected to be reasonably predictive of future experience.
Therefore, historical volatility DOES NOT provide the best basis for
forming reasonable expectations of the future price of share
options.
13
Part II
14
Part II
On 2 January 20x1, to arrest the high staff turnover rate, Maple Limited
decides to grant 100 units of cash-settled awards to each of its 300
employees on condition that the employees remain in its employment
for the next 3 years. Cash is payable at the end of 3 years (that is, on 31
December 20x3) based on the share price of Maple’s shares on that date.
15
Part II
During 20x1, 35 employees leave and Maple expects another 35 employees
in total to leave in 20x2 and 20x3. Share price of Maple Limited at the grant
date and 31 December 20x1 is $12.80 and $14.30 respectively.
During 20x3, 15 employees leave and the share price at 31 December 20x3 is
$14.00.
Maple Limited has a 31 December financial year end and it complies with the
relevant Singapore Financial Reporting Standards including SFRS(I) 2 Share-
based Payment.
16
Part II: Timeline
Share Price: $13.60
25 employees left
31 Dec x3
31 Dec x1 (Vesting Date)
02 Jan x1 31 Dec x2
(Grant Date)
Share Price: $14.30 Share Price: $14
17
Part II: Question A
Required
Prepare the necessary journal entries to account for the above cash-settled
award for the year ended 31 December 20x3.
31 Dec 20x3
Dr Staff Costs $115,533
Cr Liability - Cash Settled Share Options
$115,533 Dr Liability $315,000
Cr Cash $315,000
19
Part II: Question C
Jason, one of Maple’s key research directors, has tendered his resignation.
After due negotiations with Jason, Maple Limited grants share options to Jason
on the condition that Jason does not compete with Maple Limited for a
period of 3 years. The fair value of the award at the date of grant, including
the effect of the non-compete clause is $180,000.
Required
Discuss briefly how the grant date fair value of $180,000 should be accounted
for in the financial statements of Maple Limited.
20
Part II: Question C
Accounting Expense and equity-based share payment transaction
treatment:
Non-vesting condition
Non-compete (conditions that do not determine whether the entity receives services
clause: that entitle the employee to receive payment)
21
Part II: Question C
22
Part II: Question D (i)
“Recognising an expense when the option does not ultimately vest and
the employee receives no benefit from the award is counter-intuitive.”
Required
23
Part II: Question D (i)
2 scenarios (where
expense is recognised even though
option does not ultimately vest)
1. Non-vesting conditions
2. Vesting conditions that
are market conditions**
Illustration 4 of seminar 22
Outcome : CFO stops making the monthly contribution to the plan in the
second year and takes a refund of contribution of $15,000 over the last 15
months.
JE for accelerated vesting
Treatment : Accelerated Vesting
25
Part II: Question D (ii)
“Recognising an expense when the option does not ultimately vest and the
employee receives no benefit from the award is counter-intuitive.”
Required
26
Part D (ii)
Market conditions and non-vesting conditions are taken into account when
estimating the FV of the equity granted.
Para 21 and 21A states that for equity instrument with non-vesting and
market conditions , the entity shall recognise the goods or services received
regardless of whether that Market/Non-vesting condition is being
fulfilled
28
Part III:
On 1 November 20x2, CK Ltd engaged the services of HL Bank to provide
consultancy services on a $100,000,000 bond issuance. The fee for the
consultancy service is $520,000, similar to fees charged by other banks. CK
Ltd will issue 100,000 shares to HL Bank for the consultancy service. HL Bank
provided the consultancy service continuously over the period until the
successful completion of the bond issuance on 30 June 20x3.
29
Part III:
31/12/x2
*($520,000/8) x 2
30
Part III:
30/6/x3
Dr Consultancy Service Fee $390,000
Cr Share Based Payment Reserve $390,000
Dr Share Based Payment Reserve $520,000
Cr Share Capital
$520,000
(Optional) Dr Cash
32
$100,000,000
Part IV
33
Part IV:
A share option plan was initiated by Chatter Limited for its CEO on 1 January
20x4. The share option plan having the following terms:
a. The vesting date is 31 December 20x6 and the CEO must still remain in the
company’s employ at that date.
34
Part IV: Performance Condition:
Non-market vesting condition
b. The number of options that will vest is dependent on the average rate of
growth of earnings per share over the next three years as follows:
i. If the average rate of growth of earnings per share per year is less than
12%, the number of share options is nil.
ii. If the average rate of growth of earnings per share per year is between
12% and 20%, 180,000 share options will be given to the CEO.
iii. If the average rate of growth of earnings per share per year exceeds
20%, 250,000 share options will be given to the CEO.
35
Part IV:
Each option has an estimated fair value of $3.25 at the grant date. The
average annual growth rate of the company is not expected to be less than
12% per year. The company has the following estimations, forecasts and
actual information on its earnings:
a. Earnings per share for the year ended 31 December 20x4 increased by 15% and
the company expected this rate of growth to be maintained for the next two
years. (180,000 share options)
b. For the year ended 31 December 20x5, earnings per share increased by 26% and
the company expects the average rate of growth of earnings per share for the
three years to 31 December 20x6 to be 20.5% (average of 20x4 and 20x5 growth
rates). (250,000 share options)
c. The average rate of growth in earnings per share per year for the three-year period
ended 31 December 20x6 was 12.5%. (180,000 share options)
36
Part IV:
Required
Ignoring any tax effects, calculate the remuneration expense relating to the
share options for the period 20x4 to 20x6 and prepare the journal entries
relating to the share options for each of the years.
37
Part IV:
Journal Entries
31/12/20x4
DR Staff costs $195,000
CR Share-based payment reserve $195,000
31/12/20x5
DR Staff costs $346,667
CR Share-based payment reserve $346,667
31/12/20x6
DR Staff costs $43,333
CR Share-based payment reserve $43,333
38